ICU admission for solid cancer patients treated with immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICI) have revolutionized the management of cancer. They can induce immune-related adverse events (irAE) leading to intensive care unit (ICU) admission. We aimed to describe irAEs for ICU admissions in solid cancer patients treated with ICIs. METHODS: This pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Toffart, Anne-Claire, Meert, Anne-Pascale, Wallet, Florent, Gibelin, Aude, Guisset, Olivier, Gonzalez, Frédéric, Seguin, Amélie, Kouatchet, Achille, Delaunay, Myriam, Debieuvre, Didier, Duchemann, Boris, Rousseau-Bussac, Gaëlle, Nyunga, Martine, Grimaldi, David, Levrat, Albrice, Azoulay, Elie, Lemiale, Virginie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113402/
https://www.ncbi.nlm.nih.gov/pubmed/37072645
http://dx.doi.org/10.1186/s13613-023-01122-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113402/
https://www.ncbi.nlm.nih.gov/pubmed/37072645
http://dx.doi.org/10.1186/s13613-023-01122-z

Ejemplares similares